Comparison of oxidative stress markers in HIV‐infected patients on efavirenz or atazanavir/ritonavir‐based therapy

Vicente Estrada(Instituto de Salud Carlos III), José Ramón Blanco, Paz Sobrino‐Vegas, Susana Monge(Instituto de Salud Carlos III), Juan Berenguer(Instituto de Salud Carlos III), Estebán Martínez(Instituto de Salud Carlos III), Dulcenombre Gómez‐Garré(Universidad Complutense de Madrid), Jesús Santos(Hospital Clínico Universitario Virgen de la Victoria), José Ignacio Bernardino(Hospital Universitario La Paz)
Journal of the International AIDS Society
November 1, 2014
10.7448/ias.17.4.19544
Cited by 11

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423